MolNFT v1 · #125245 · protein
Fragment-based discovery of 6-arylindazole JAK inhibitors
5L3A · Tyrosine-protein kinase JAK2: “Fragment-based discovery of 6-arylindazole JAK inhibitors”. X-ray diffraction, 1 ligand (6DP), 2 pockets (best druggability 0.70). MolNFT v1 #125245 on GenesisL1: 3D structure, binding sites and…
- PDB
- 5L3A
- Type
- protein
- Length
- 290 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tyrosine-protein kinase JAK2
- EC
- 2.7.10.2
- UniProt
- O60674
- Ligands
- 6DP
- Pockets
- 2 · best druggability 0.70
Structure
x-ray diffraction · 1 distinct chain · 44% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tyrosine-protein kinase JAK2 (EC 2.7.10.2) | protein | 290 | 44% helix, 18% strand | O60674 |
Ligands and binding sites
- 6DP · ~{N}-(1~{H}-indazol-4-yl)methanesulfonamide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 487 | 0.70 | 0.80 | 55 | 6DP |
| 2 | 95 | 0.36 | 0.75 | 23 | empty |
Compared structures
- 5L3A · Fragment-based discovery of 6-arylindazole JAK inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O60674
- Elsewhere: RCSB PDB 5L3A · PDBe 5L3A · UniProt O60674
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.